The rise of fragment-based drug discovery
作者： Christopher W. Murray , David C. Rees
DOI: 10.1038/NCHEM.217
关键词:
摘要: … back, in part, to the quality of the chemical leads. Fragment-based drug discovery (FBDD) is a … clinical candidates against targets for which other chemistry approaches have struggled. …
harvard.edu
nature.com
sci-hub.se 参考文章(48)
Cheol-Min Park, Milan Bruncko, Jessica Adickes, Joy Bauch, Hong Ding, Aaron Kunzer, Kennan C. Marsh, Paul Nimmer, Alexander R. Shoemaker, Xiaohong Song, Stephen K. Tahir, Christin Tse, Xilu Wang, Michael D. Wendt, Xiufen Yang, Haichao Zhang, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. Journal of Medicinal Chemistry. ,vol. 51, pp. 6902- 6915 ,(2008) , 10.1021/JM800669S
Andrew R. Leach, Michael M. Hann, Jeremy N. Burrows, Ed J. Griffen, Fragment screening: an introduction. Molecular BioSystems. ,vol. 2, pp. 429- 446 ,(2006) , 10.1039/B610069B
S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik, Discovering High-Affinity Ligands for Proteins: SAR by NMR Science. ,vol. 274, pp. 1531- 1534 ,(1996) , 10.1126/SCIENCE.274.5292.1531
Miles Congreve, Christopher W. Murray, Tom L. Blundell, Keynote review: Structural biology and drug discovery Drug Discovery Today. ,vol. 10, pp. 895- 907 ,(2005) , 10.1016/S1359-6446(05)03484-7
D. J. Haydon, N. R. Stokes, R. Ure, G. Galbraith, J. M. Bennett, D. R. Brown, P. J. Baker, V. V. Barynin, D. W. Rice, S. E. Sedelnikova, J. R. Heal, J. M. Sheridan, S. T. Aiwale, P. K. Chauhan, A. Srivastava, A. Taneja, I. Collins, J. Errington, L. G. Czaplewski, An Inhibitor of Ftsz with Potent and Selective Anti-Staphylococcal Activity. Science. ,vol. 321, pp. 1673- 1675 ,(2008) , 10.1126/SCIENCE.1159961
Miles Congreve, Robin Carr, Chris Murray, Harren Jhoti, A 'rule of three' for fragment-based lead discovery? Drug Discovery Today. ,vol. 8, pp. 876- 877 ,(2003) , 10.1016/S1359-6446(03)02831-9
Alessio Ciulli, Chris Abell, Fragment-based approaches to enzyme inhibition. Current Opinion in Biotechnology. ,vol. 18, pp. 489- 496 ,(2007) , 10.1016/J.COPBIO.2007.09.003
Michal Vieth, Miles G. Siegel, Richard E. Higgs, Ian A. Watson, Daniel H. Robertson, Kenneth A. Savin, Gregory L. Durst, Philip A. Hipskind, Characteristic physical properties and structural fragments of marketed oral drugs. Journal of Medicinal Chemistry. ,vol. 47, pp. 224- 232 ,(2004) , 10.1021/JM030267J
Miles Congreve, Gianni Chessari, Dominic Tisi, Andrew J. Woodhead, Recent developments in fragment-based drug discovery. Journal of Medicinal Chemistry. ,vol. 51, pp. 3661- 3680 ,(2008) , 10.1021/JM8000373
W. P. Jencks, On the attribution and additivity of binding energies. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 78, pp. 4046- 4050 ,(1981) , 10.1073/PNAS.78.7.4046